EUCTR2016-000810-31-NL进行中(未招募)1 期
Impact of L-Carnitine infusion on Lipid induced Insulin resistance - Carnitine infusion and Insulin resistance
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中(未招募)
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Male
入选标准
- •Healthy (as determined by responsible physician based on a medical questionnaire)
- •Age: 18-40 years
- •Normal BMI: 18-25 kg/m2
- •Stable dietary habits
- •No use of medication interfering with investigated study parameters (as determined by responsible physician)
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 18
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range 0
排除标准
- •Haemoglobin levels < 7.8 mmol/L
- •Uncontrolled hypertension
- •Use of anticoagulants
- •Engagement in exercise > 3 hours a week
- •Being vegetarian or vegan (because of altered whole body carnitine status)
- •Alcohol and/or drug abuse
- •Unstable body weight (weight gain or loss > 5kg in the last 3 months)
- •Significant food allergies/intolerances (seriously hampering study meals)
- •Participation in another biomedical study within 1 month before the first study visit, which would possibly hamper our study results
- •Medication use known to hamper subject’s safety during the study procedures
- •Medication use known to interfere with investigated study parameters
- •Subjects with contra-indications for MRI
- •Subjects who intend to donate blood during the intervention or subjects who have donated blood less than three months before the start of the study
- •Subjects who do not want to be informed about unexpected medical findings
- •Subjects who do not want that their treating physician is informed
研究者
相似试验
已完成
不适用
Impact of L-Carnitine infusion on Lipid induced Insulin resistancenoninsulin dependant diabetestype 2 diabetes mellitus10018424NL-OMON43461niversiteit Maastricht21
已完成
不适用
Effect of L - carnitine in patients with hyperlipidemiaHyperlipidemia.HyperlipidemiaIRCT2014011411920N2Baqiyatallah University of Medical Sciences60
招募中
不适用
The effect of intravenous L-carnitine treatment on hemodialysis patientsJPRN-UMIN000011208Toda Central General Hospital80
已完成
3 期
Effect of L-Carnitine (LC) and conjugated linoleic acid (CLA) supplements on hemoglobin levels in CKD patientsRenal failure.N18.2-N18.4N17- N19IRCT201503055144N7Vice Chancellor for Research Ardabil University of Medical Sciences40
已完成
不适用
Effect of L-Carnitine injection product associated with muscle sympton, renal anemia and cardiac function in dialysis patients.JPRN-UMIN000012390Juntendo University60
